Molecular prediction of clinical response to <scp>anti‐PD</scp> ‐1/ <scp>anti‐PD‐L1</scp> immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry‐based investigations-Reference-Cited by-同舟云学术

Molecular prediction of clinical response to anti‐PD ‐1/ anti‐PD‐L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry‐based investigations

Published:2022-11-30 Issue: Volume: Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Longuespée Rémi¹^ORCID,Theile Dirk¹^ORCID,Zörnig Inka²,Hassel Jessica C.³,Lindner Joshua Raoul¹,Haefeli Walter E.¹,Fresnais Margaux¹^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Pharmacoepidemiology Heidelberg University Hospital Heidelberg Germany

2. Department of Medical Oncology and National Center for Tumor Diseases Heidelberg University Hospital Heidelberg Germany

3. Department of Dermatology and National Center for Tumor Diseases Heidelberg University Hospital Heidelberg Germany

Funder

Deutsche Forschungsgemeinschaft

Dietmar Hopp Stiftung

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34366

Reference85 articles.

1. Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies

2. Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

3. Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond

4. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

5. FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients;Frontiers in Pharmacology;2024-05-31

2. Comprehensive analysis of prognostic value and immune infiltration of IAPs family in hepatocellular carcinoma;Journal of Cancer;2023

3. Immunotherapy Against Cancer Stem Cells;Cancer Stem Cells: Basic Concept and Therapeutic Implications;2023

4. Role of ICIs-Based Therapies and Bevacizumab for Advanced Wild-Type Non-Squamous NSCLC in the First-Line Setting: A Bayesian Network Analysis;2023